Globally, more than 5 million people die annually from lack of access to critical treatments for
kidney disease—by 2040, chronic kidney disease is projected to be the fifth leading cause of …

Kidney disease is the 10th leading cause of death worldwide and disproportionately
increases morbidity and mortality for people residing in low-and middle-income countries …

Background Screening for chronic kidney disease is a challenge in community and primary
care settings, even in high-income countries. We developed an artificial intelligence deep …

Background Chronic kidney disease (CKD) is a global public health concern, but its disease
burden and risk-attributable burden in CKD has been poorly studied in low-and middle …

We have developed a digital twin-based CKD identification and prediction model that
leverages generalized metabolic fluxes (GMF) for patients with Type 2 Diabetes Mellitus …

Abstract The United Nations 2030 agenda for sustainable development includes 17
sustainable development goals (SDGs) that represent a universal call to end poverty and …

Metabolic acidosis (MA) may play a key role in the pathogenesis of protein‐energy wasting
(PEW) in patients with chronic kidney disease (CKD). To present a comprehensive synthesis …

Context.—Point-of-care testing allows rapid analysis and short turnaround times. To the best
of our knowledge, the present study assesses, for the first time, clinical, operative, and …

Rural riverside are restricted geographic areas with poor health care system. Limited data
exist on the magnitude of dehydration and renal disorders in these areas. The present study …

Introduction Chronic kidney disease (CKD) affects 10% of the global population, with an
estimated total population of 850 million with underlying CKD. 1 According to the report …